Sanofi Research and Development Expenses 2010-2024 | SNY

Sanofi research and development expenses for the twelve months ending December 31, 2024 were $8.001B, a 9.88% increase year-over-year.

  • Sanofi annual research and development expenses for 2024 were $8.001B, a 9.88% increase from 2023.
  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
  • Sanofi annual research and development expenses for 2022 were $7.065B, a 4.92% increase from 2021.

Sanofi Research and Development Expenses 2010-2024 | SNY

  • Sanofi annual research and development expenses for 2024 were $8.001B, a 9.88% increase from 2023.
  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
  • Sanofi annual research and development expenses for 2022 were $7.065B, a 4.92% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B